Haemonetics Corporation

400 Wood Rd , Braintree, MA 02184

Public
Healthcare & Pharmaceuticals - Medical Devices
around $100 - 500M
around 1K - 5K
(781) 848-7100
info@wyndgate.com


Haemonetics Corporation is a healthcare company. The Company is engaged developing and manufacturing automated blood component collection devices and surgical blood salvage devices. The Company offer devices and related consumables, information technology software platforms, and consulting services. Its customers are blood and plasma collectors, hospitals and health care providers globally. The Company has four global product families: plasma, blood center, hospital, and software solutions. Its products include equipment devices and the related disposables used with these devices. Disposables include the plasma, blood center and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components. In August 2012, Pall Corporat... (Source: SEC reports)


Competitor - 1/7
Which company is more competitive with Haemonetics Corporation?


178 Contacts at this company
Tammy Roalsvig
Project Manager
Gerard J. Gould
Board of Directors and Finance / Audit
Patrick Curran
Sr. Manager, North America Region ...
Michelle Leo
Senior Manager, Global Clinical Marketing ...
Clifford Yee
System Implementation Lead
Jill Robinson
Program Manager, Global Marketing ...
Michael Ragusa
Vice President, Global Research ...
Heidi Held
Director, Global Benefits
Harry Carey
VP, Legal and Associate General Counsel

Oct 10, 2017 20:42:41
BRAINTREE, Mass., Oct. 10, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will publish second quarter and first half fiscal 2018 financial results at 6:00 [...]

Sep 14, 2017 18:37:07
BRAINTREE, Mass., Sept. 14, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the appointment of David J. Wilson as President, Plasma Business Unit, effective September 18, 2017.  [...]

Aug 29, 2017 21:37:34
BRAINTREE, Mass., Aug. 29, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley\'s Global Healthcare Conference in [...]

Jun 22, 2017 21:38:24
BRAINTREE, Mass., June 22, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the formation of a Scientific Advisory Council (\"SAC\") as part of its broader innovation agenda, [...]

Jun 14, 2017 20:43:00
BRAINTREE, Mass., June 14, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) will webcast the management presentations and the question and answer period of its investor and analyst meeting [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.